Skin News and Research

RSS

BREVENA Laboratories receives National Eczema Association's Seal of Acceptance award for Restorative Skin Balm

BREVENA Laboratories, LLC, a luxury skincare cosmetics company that combines beauty and advanced medical technology, announces that the National Eczema Association has awarded the Seal of Acceptance to the brand's Restorative Skin Balm.

15 Oct 2015

How important is a mother’s diet before pregnancy? An interview with Dr Matt Silver

In humans, much is already known about the impact of maternal undernutrition during pregnancy, and its impact on growth, development and disease throughout the life course. However, until recently little was known about the effects of the nutritional environment around the time of conception.

14 Oct 2015

Tips to treat, prevent common warts

Warts aren't just for witches and goblins. According to member dermatologists from the American Academy of Dermatology, children and teens, people who frequently bite their nails, and people with a weakened immune system are more prone to getting warts than others.

14 Oct 2015

VTT examines effectiveness of beauty patch using unique imaging technology

VTT Technical Research Centre of Finland has analysed the effectiveness of its beauty patch, using a technique for imaging live tissue to demonstrate the patch's beneficial effects on the skin. Preliminary results show that already after two weeks usage the patch together with cosmetic serum adds collagen, which helps skin tissue to stay supple.

14 Oct 2015

Drug-resistant E. coli infections on the rise in community hospitals

Drug-resistant E. coli infections are on the rise in community hospitals, where more than half of U.S. patients receive their health care, according to a new study from Duke Medicine.

14 Oct 2015

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Eli Lilly and Company and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential novel T-cell-based immuno-oncology therapies.

13 Oct 2015

Phase III trial data shows Novartis’ Cosentyx maintains clear skin, sustained efficacy in psoriasis patients

Novartis announced today new late-breaking data demonstrating that CosentyxTM provides high levels of skin clearance and sustained efficacy in patients with moderate-to-severe plaque psoriasis while maintaining a favorable safety profile across three years.

13 Oct 2015

Researchers use high-precision instrument to inject toxins that reduce migraine attacks

Researchers are using a high-precision instrument to inject toxins that alleviate migraine attacks. This means even better needle guidance and user-friendliness.

13 Oct 2015

Prostate Cells Undergo 'Reprogramming' To Form Tumors, Study Finds

Scientists have gained a key insight into how prostate tumors get their start - not by rewriting the normal DNA code, but by reprogramming the master regulator of genes in prostate cells to drive malignant growth.

12 Oct 2015

MiNDERA closes $1 million Seed financing round

MiNDERA Corp., a leader in non-invasive molecular diagnostics for dermatology and skin-related cancers, announced today the close of its $1 million Seed financing round. Scientific Health Development and other individual investors are among MiNDERA's new investors. This financing round will enable MINDERA to further validate its proprietary micro-needle technology and prepare for the launch of its first research products.

12 Oct 2015

Study looks at survival benefits of surgical resection for melanoma patients with abdominal metastases

Patients with metastatic melanoma who undergo surgery to remove lesions that have spread into the abdomen live more than twice as long as those treated with drug therapy alone, according to novel new research by a North Shore-LIJ Health System cancer surgeon.

12 Oct 2015

Scientists can now use skin samples from older patients to grow brain cells

For the first time, scientists can use skin samples from older patients to create brain cells without rolling back the youthfulness clock in the cells first. The new technique, which yields cells resembling those found in older people's brains, will be a boon to scientists studying age-related diseases like Alzheimer's and Parkinson's.

9 Oct 2015

Scientists engineer stem cells to better understand mechanisms behind leukemia

Scientists engineered stem cells to better understand the mechanisms behind a form of leukemia caused by changes in a key gene, according to a study led by Mount Sinai researchers and published online today in the journal Cell Reports.

9 Oct 2015

FDA approves Lonsurf drug for patients with advanced form of colorectal cancer

The U.S. Food and Drug Administration today approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with an advanced form of colorectal cancer who are no longer responding to other therapies.

9 Oct 2015

FDA approves expanded indication for Optune device for brain cancer patients

The U.S. Food and Drug Administration today approved an expanded indication for the Optune device to treat patients with newly-diagnosed glioblastoma multiforme (GBM), an aggressive form of brain cancer.

9 Oct 2015

FDA approves Promacta to treat pediatric patients with chronic immune thrombocytopenic purpura

The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). Promacta can be used in these children when they have not achieved an appropriate response using other ITP medicines or surgery to remove the spleen.

9 Oct 2015

Tresiba and Ryzodeg approved to improve blood sugar control in adults with diabetes mellitus

The U.S. Food and Drug Administration today approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve blood sugar (glucose) control in adults with diabetes mellitus.

9 Oct 2015

EpiPen autoinjectors save lives but can contribute to injuries in children

Epinephrine autoinjectors can be life-saving for patients experiencing anaphylaxis - a life-threatening emergency - but a new case series published online Tuesday in Annals of Emergency Medicine identifies design features of EpiPens, the most commonly used autoinjector, that appear to be contributing to injuries in children ("Lacerations and Embedded Needles Caused by Epinephrine Autoinjector Use in Children").

9 Oct 2015

Manchester researchers demonstrate safety, effectiveness of eltrombopag treatment in children with ITP

Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.

9 Oct 2015

Antioxidants can increase rate of melanoma metastasis in mice

Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice. The results reinforce previous findings that antioxidants hasten the progression of lung cancer. According to Professor Martin Bergö, people with cancer or an elevated risk of developing the disease should avoid nutritional supplements that contain antioxidants.

9 Oct 2015

Skin News and Research

BREVENA Laboratories receives National Eczema Association's Seal of Acceptance award for Restorative Skin Balm

How important is a mother’s diet before pregnancy? An interview with Dr Matt Silver

Tips to treat, prevent common warts

VTT examines effectiveness of beauty patch using unique imaging technology

Drug-resistant E. coli infections on the rise in community hospitals

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Phase III trial data shows Novartis’ Cosentyx maintains clear skin, sustained efficacy in psoriasis patients

Researchers use high-precision instrument to inject toxins that reduce migraine attacks

Prostate Cells Undergo 'Reprogramming' To Form Tumors, Study Finds

MiNDERA closes $1 million Seed financing round

Study looks at survival benefits of surgical resection for melanoma patients with abdominal metastases

Scientists can now use skin samples from older patients to grow brain cells

Scientists engineer stem cells to better understand mechanisms behind leukemia

FDA approves Lonsurf drug for patients with advanced form of colorectal cancer

FDA approves expanded indication for Optune device for brain cancer patients

FDA approves Promacta to treat pediatric patients with chronic immune thrombocytopenic purpura

Tresiba and Ryzodeg approved to improve blood sugar control in adults with diabetes mellitus

EpiPen autoinjectors save lives but can contribute to injuries in children

Manchester researchers demonstrate safety, effectiveness of eltrombopag treatment in children with ITP

Antioxidants can increase rate of melanoma metastasis in mice

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News